Turan Nefize, Heider Robert A, Roy Anil K, Miller Brandon A, Mullins Mark E, Barrow Daniel L, Grossberg Jonathan, Pradilla Gustavo
Department of Neurosurgery, Emory University School of Medicine, Atlanta, Georgia, USA.
Department of Radiology, Duke University School of Medicine, Durham, North Carolina, USA.
World Neurosurg. 2018 May;113:280-292. doi: 10.1016/j.wneu.2018.01.054. Epub 2018 Jan 31.
Intracranial aneurysms (IAs) are pathologic dilatations of cerebral arteries. This systematic review summarizes and compares imaging techniques for assessing unruptured IAs (UIAs). This review also addresses their uses in different scopes of practice. Pathophysiologic mechanisms are reviewed to better understand the clinical usefulness of each imaging modality.
A literature review was performed using PubMed with these search terms: "intracranial aneurysm," "cerebral aneurysm," "magnetic resonance angiography (MRA)," computed tomography angiography (CTA)," "catheter angiography," "digital subtraction angiography," "molecular imaging," "ferumoxytol," and "myeloperoxidase". Only studies in English were cited.
Since the development and improvement of noninvasive diagnostic imaging (computed tomography angiography and magnetic resonance angiography), many prospective studies and meta-analyses have compared these tests with gold standard digital subtraction angiography (DSA). Although computed tomography angiography and magnetic resonance angiography have lower detection rates for UIAs, they are vital in the treatment and follow-up of UIAs. The reduction in ionizing radiation and lack of endovascular instrumentation with these modalities provide benefits compared with DSA. Novel molecular imaging techniques to detect inflammation within the aneurysmal wall with the goal of stratifying risk based on level of inflammation are under investigation.
DSA remains the gold standard for preoperative planning and follow-up for patients with IA. Newer imaging modalities such as ferumoxytol-enhanced magnetic resonance imaging are emerging techniques that provide critical in vivo information about the inflammatory milieu within aneurysm walls. With further study, these techniques may provide aneurysm rupture risk and prediction models for individualized patient care.
颅内动脉瘤(IA)是脑动脉的病理性扩张。本系统评价总结并比较了评估未破裂颅内动脉瘤(UIA)的成像技术。本评价还探讨了它们在不同实践范围内的应用。对病理生理机制进行综述,以更好地理解每种成像方式的临床实用性。
使用PubMed进行文献综述,搜索词如下:“颅内动脉瘤”、“脑动脉瘤”、“磁共振血管造影(MRA)”、计算机断层血管造影(CTA)、“导管血管造影”、“数字减影血管造影”、“分子成像”、“ ferumoxytol”和“髓过氧化物酶”。仅引用英文研究。
自从无创诊断成像(计算机断层血管造影和磁共振血管造影)发展和改进以来,许多前瞻性研究和荟萃分析已将这些检查与金标准数字减影血管造影(DSA)进行了比较。尽管计算机断层血管造影和磁共振血管造影对UIA的检测率较低,但它们在UIA的治疗和随访中至关重要。与DSA相比,这些方式减少了电离辐射且无需血管内器械操作,具有一定优势。正在研究新型分子成像技术,以检测动脉瘤壁内的炎症,目的是根据炎症水平对风险进行分层。
DSA仍然是IA患者术前规划和随访的金标准。较新的成像方式,如ferumoxytol增强磁共振成像,是新兴技术,可提供有关动脉瘤壁内炎症环境的关键体内信息。随着进一步研究,这些技术可能为个体化患者护理提供动脉瘤破裂风险和预测模型。